Nanocurcumin Promising Candidate for Therapeutic Applications

PDF Publication Title:

Nanocurcumin Promising Candidate for Therapeutic Applications ( nanocurcumin-promising-candidate-therapeutic-applications )

Previous Page View | Next Page View | Return to Search List

Text from PDF Page: 008

Karthikeyan et al. Nanocurcumin: A Promising Candidate for Therapeutic Applications TABLE 2 | Continued S. No 11 12 Curcumin nanoformulation Nanogels Nanodisks Description contains internal core and outer polymeric shell. A nanogel is a nanoparticle composed of a hydrogel synthesized by either physical or chemical cross-linking of polymers under controlled conditions. Cross linked structure of nanogels offer a strong base for drug storage and release. It is a possible technique to prepare and release active types of drugs like curcumin to cells for remaining activity, improving stability, and prevent drug immunogenicity Nanodisks are disk-shaped bilayers, apolipoprotein-stabilized and self- assembled. They boost the solubility and targeted release of curcumin Models used Candida albicans. Breast cancer cells, melanoma cells, and Alzheimer’s Pancreatic cancer, colorectal cancer and skin cancer cells Mantle cell lymphoma Major outcomes Targeted and controlled drug release, prolong circulation, enhanced bio availability, and better anticancer activity Improved biological activity and apotopsis to mantle cell lymphoma and anticancer activity References 2019; Masoule et al., 2019; Kim et al., 2020 Mangalathillam et al., 2012; Wei et al., 2013; Madhusudana Rao et al., 2015; Amanlou et al., 2019; Wang et al., 2019; Priya et al., 2020 Ghosh et al., 2011; Singh et al., 2011; Subramani et al., 2017 nanoparticles (CUR-SLNs) displayed the extended cell uptake and obstruction of growth in cancer cells with improved dispersibility and chemical stability of the drug (Sun et al., 2013). CUR-SLNs were examined for its anticancer activity in breast adenocarcinoma cells (MDA-MB-231). CUR-SLNs showed high solubility and support to drug release in comparison to the native curcumin. Besides, CUR-SLNs induced significantly higher apoptosis in MDA-MB-231 cells. The results suggest CUR-SLNs be useful for cancer treatment (Bhatt et al., 2018). Recently, CURC-SLNs coupled with doxorubicin and used to overcome the Pgp-mediated chemoresistance in triple negative breast cancer cells (TNBC). This formulation appears to be effective and safe due to high biocompatibility and lower toxicity (Fathy Abd-Ellatef et al., 2020). Magnetic nanoparticles consist of a metal or metallic oxide core that can be functionalized within a polymer or inorganic metal coating. This coating confirms the stability and biocompatibility of the magnetic nanoparticles. They are easily manipulated in size, shape, and chemical properties. Magnetic nanoparticles also have unique physical properties, are biocompatible with the human body, and have a low production cost (Roacho-Pérez et al., 2020). Iron oxide nanoparticle core covered by CD and pluronic polymer (F68) with curcumin showed enhanced uptake in cancer cells. This formulation inhibits the potential of the mitochondrial membrane and produces more ROS than unformulated curcumin. Also, it exhibited a strong anticancer effect together with resonance imaging characteristics and magnetic targeting abilities (Yallapu et al., 2012b). The sustainable delivery of thiolated starch-coated iron oxide nanoparticles containing curcumin displayed significant compatibility of the system in lymphocyte cells. It also caused the cytotoxicity on cancer cell lines due to its higher drug encapsulation, stability, and loading efficiency (Saikia et al., 2017). In another investigation, curcumin loaded Fe3O4-magnetic nanoparticles (MNPs) showed an excellent uptake and helpful for drug releases in tumor tissues. Besides, this formulation accompanied by imaging applications in tumor tissues (Aeineh et al., 2018). Recently, magnetic nanoparticles decorated with PEGylated curcumin (MNP@ PEG-Cur) were confirmed as highly biocompatible drug carriers for antitumor medicine (Ayubi et al., 2019). Albumin is the ideal material and preferable protein carrier for drug delivery due to nontoxic, biocompatible, biodegradable, and high binding capacity with different drugs. Kim et al. study revealed that curcumin-loaded human serum albumin (HSA) nanoparticles (CCM-HSA-NPs) exhibited an enhanced in vivo antitumor activity compared to unformulated curcumin in a tumor xenograft animal model, with no toxicity (Kim et al., 2011). Also, experimental data from this study suggested that this formulation is a potential drug delivery system for curcumin in the treatment of cancer. Further, Thadakapally et al. showed that PEG-albumin-curcumin (PAC) nanoparticles have significant anticancer activity in breast cancer lines with stable long circulation and better solubility (Thadakapally et al., 2016). Gold nanoparticles have novel optical and catalytic properties that are non-toxic and biocompatible and drawn significant interest in a variety of applications. In recent years, gold nanoparticles synthesized with plant extracts widely used for the biomedical area (Nambiar et al., 2018). Colloidal stability of these particles keeps the physicochemical properties unchanging. Thus, no changes will occur in the biological activity of the particles. The study conducted using curcumin-encapsulated chitosan-graft-poly(N-vinyl caprolactam) nanoparticles containing gold nanoparticles (Au-CRC-TRC-NPs) showed targeted delivery of drug and apoptosis to colon cancer cells (Rejinold et al., 2015). In another research, Nambiar et al. synthesized curcumin gold nanoparticles (cur-AuNPs) using cell-culture medium supplemented with or without fetal bovine serum (FBS) and confirmed their anticancer effects in human prostate cancer cells (Nambiar et al., 2018). The gold nanoparticles with curcumin (CWAuNPs) examined for its Frontiers in Pharmacology | www.frontiersin.org 8 May 2020 | Volume 11 | Article 487

PDF Image | Nanocurcumin Promising Candidate for Therapeutic Applications

PDF Search Title:

Nanocurcumin Promising Candidate for Therapeutic Applications

Original File Name Searched:

fphar-11-00487.pdf

DIY PDF Search: Google It | Yahoo | Bing

CO2 Organic Rankine Cycle Experimenter Platform The supercritical CO2 phase change system is both a heat pump and organic rankine cycle which can be used for those purposes and as a supercritical extractor for advanced subcritical and supercritical extraction technology. Uses include producing nanoparticles, precious metal CO2 extraction, lithium battery recycling, and other applications... More Info

Heat Pumps CO2 ORC Heat Pump System Platform More Info

CONTACT TEL: 608-238-6001 Email: greg@infinityturbine.com (Standard Web Page)